Daniel A. Hamstra

8.3k total citations · 2 hit papers
159 papers, 5.0k citations indexed

About

Daniel A. Hamstra is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel A. Hamstra has authored 159 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pulmonary and Respiratory Medicine, 54 papers in Radiation and 34 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel A. Hamstra's work include Prostate Cancer Diagnosis and Treatment (88 papers), Prostate Cancer Treatment and Research (74 papers) and Advanced Radiotherapy Techniques (54 papers). Daniel A. Hamstra is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (88 papers), Prostate Cancer Treatment and Research (74 papers) and Advanced Radiotherapy Techniques (54 papers). Daniel A. Hamstra collaborates with scholars based in United States, Canada and Israel. Daniel A. Hamstra's co-authors include Alnawaz Rehemtulla, Brian D. Ross, Thomas L. Chenevert, Howard M. Sandler, Timothy D. Johnson, Theodore S. Lawrence, Charles R. Meyer, Felix Y. Feng, Christina Tsien and Larry Junck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Investigation.

In The Last Decade

Daniel A. Hamstra

145 papers receiving 4.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy

2016 229 citations Jason A. Efstathiou, Thomas M. Pisansky et al. Journal of Clinical Oncology profile →
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer

2018 225 citations Jeff M. Michalski, Daniel A. Hamstra et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel A. Hamstra	2.0k	1.7k	1.1k	806	710	159	5.0k
Susan Short	1.2k 0.6×	1.5k 0.9×	1.4k 1.2×	622 0.8×	708 1.0×	159	4.2k
James M. Larner	1.8k 0.9×	851 0.5×	1.1k 1.0×	843 1.0×	943 1.3×	151	4.3k
E. Brian Butler	2.1k 1.0×	842 0.5×	792 0.7×	917 1.1×	1.2k 1.7×	227	4.7k
Steve Braunstein	1.2k 0.6×	779 0.5×	1.2k 1.1×	488 0.6×	1.0k 1.4×	205	4.2k
Arnold M. Markoe	1.6k 0.8×	1.1k 0.6×	515 0.5×	889 1.1×	1.1k 1.6×	203	4.9k
Amir Abdollahi	2.3k 1.1×	1.1k 0.6×	2.6k 2.3×	1.0k 1.3×	1.5k 2.1×	212	6.5k
Rie von Eyben	1.3k 0.7×	829 0.5×	700 0.6×	629 0.8×	1.0k 1.4×	166	3.8k
Kazuhiko Ogawa	2.0k 1.0×	900 0.5×	1.2k 1.1×	1.1k 1.3×	1.3k 1.8×	320	5.7k
Robert A. Lustig	1.7k 0.9×	997 0.6×	567 0.5×	558 0.7×	816 1.1×	123	4.3k
Michael Bamberg	2.3k 1.2×	1.0k 0.6×	1.3k 1.2×	638 0.8×	1.0k 1.4×	179	6.9k

Countries citing papers authored by Daniel A. Hamstra

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Hamstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Hamstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Hamstra more than expected).

Fields of papers citing papers by Daniel A. Hamstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Hamstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Hamstra. The network helps show where Daniel A. Hamstra may publish in the future.

Co-authorship network of co-authors of Daniel A. Hamstra

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Hamstra. A scholar is included among the top collaborators of Daniel A. Hamstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Hamstra. Daniel A. Hamstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Collins, Sean P., et al.. (2025). Association Between Rectal Spacer Use and Erectile Dysfunction Diagnosis Among Men Receiving Prostate Radiotherapy: US County‐Level Analysis. Cancer Medicine. 14(24). e71362–e71362.

Folkert, Michael R., et al.. (2025). Bowel Disorder Incidence and Rectal Spacer Use in Patients With Prostate Cancer Undergoing Radiotherapy. JAMA Network Open. 8(3). e250491–e250491. 1 indexed citations

Jhavar, Sameer, et al.. (2024). Cervical Clear Cell Adenocarcinoma: Real-World Insights on Patient Profiles, Treatments and Comparative Efficacy of Locoregional Treatments. International Journal of Radiation Oncology*Biology*Physics. 120(2). e692–e692.

Malhotra, Jyoti, Mona Arbab, Matthew P. Deek, et al.. (2024). Two phase 2A clinical trials to evaluate the safety and efficacy of IMSA101 in combination with radiotherapy and checkpoint inhibitors in oligometastatic and oligoprogressive solid tumor malignancies.. Journal of Clinical Oncology. 42(16_suppl). TPS2685–TPS2685. 4 indexed citations

Dong, E, Junqian Xu, Jason Bryan, et al.. (2024). Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer. Radiation Oncology. 19(1). 35–35. 1 indexed citations

Baliga, Sujith, Samir Patel, Issam El Naqa, et al.. (2023). Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 119(2). 610–624. 8 indexed citations

Sun, Grace, Donna M. Edwards, David A. Elliott, et al.. (2023). Association of Proton Pump Inhibitor Use and Severe Pneumonitis in Stage III Non-Small-Cell Lung Cancer Treated with Primary Chemoradiation and Adjuvant Durvalumab. International Journal of Radiation Oncology*Biology*Physics. 117(2). e61–e61. 1 indexed citations

Hamstra, Daniel A., Stephanie L. Pugh, Herbert Lepor, et al.. (2019). Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. Radiotherapy and Oncology. 141. 137–143. 6 indexed citations

Hamstra, Daniel A., Kyounghwa Bae, Gerald E. Hanks, et al.. (2014). Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer. 121(6). 844–852. 2 indexed citations

10.

Liss, Adam L., Jessica Zhou, Cheryl Evans, et al.. (2014). Anatomic Variability of the Neurovascular Elements Defined by MRI. Brachytherapy. 13. S42–S43. 7 indexed citations

11.

Shilkrut, Mark, Patrick W. McLaughlin, Gregory S. Merrick, Jeffrey M. Vainshtein, & Daniel A. Hamstra. (2014). Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy. American Journal of Clinical Oncology. 39(2). 181–188. 9 indexed citations

12.

Johnson, Skyler B., Will Jackson, Corey C. Foster, et al.. (2013). The Interval to Biochemical Failure Is Prognostic for Metastasis, Prostate Cancer-Specific, and Overall Mortality Following Salvage Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(2). S396–S396. 1 indexed citations

13.

Gray, Phillip J., Jonathan J. Paly, Beow Y. Yeap, et al.. (2013). Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer. Cancer. 119(9). 1729–1735. 72 indexed citations

14.

Hamstra, Daniel A., Dale W. Litzenberg, Will Jackson, et al.. (2012). Age and Comorbid Illness Are Associated With Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1246–1253. 40 indexed citations

15.

Tsien, Christina, Craig J. Galbán, Thomas L. Chenevert, et al.. (2010). Parametric Response Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma. Journal of Clinical Oncology. 28(13). 2293–2299. 159 indexed citations

16.

Hamstra, Daniel A., Avraham Eisbruch, Gogula V. Ramana, et al.. (2010). Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck Cancer. Clinical Cancer Research. 16(9). 2666–2676. 21 indexed citations

17.

Murphy, James D., et al.. (2009). Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature. Clinical Cancer Research. 15(2). 589–596. 40 indexed citations

18.

Vuyyuri, Saleha B., Daniel A. Hamstra, Christin A. Hamilton, et al.. (2008). Evaluation of d -Methionine as a Novel Oral Radiation Protector for Prevention of Mucositis. Clinical Cancer Research. 14(7). 2161–2170. 47 indexed citations

19.

Hamstra, Daniel A., Craig J. Galbán, Charles R. Meyer, et al.. (2008). Functional Diffusion Map As an Early Imaging Biomarker for High-Grade Glioma: Correlation With Conventional Radiologic Response and Overall Survival. Journal of Clinical Oncology. 26(20). 3387–3394. 214 indexed citations

20.

Contessa, Joseph N. & Daniel A. Hamstra. (2007). Revoking the Privilege: Targeting HER2 in the Central Nervous System. Molecular Pharmacology. 73(2). 271–273. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact